16 Infos zu Niklas Gremke

1 Aktuelle Nachrichten

2 Dokumente

Inactivation of the p53 tumor suppressor by Mdm2 is one of the most frequent events in cancer, so compounds targeting the p53-Mdm2 interaction are...

· Michael Wanzel 1,* , Niklas Gremke 1, Lea Schmoll 1, and Thorsten Stiewe 1. 1Center for Tumor Biology and Immunology (ZTI).

1 Allgemeine Veröffentlichungen

Anne Catherine Bretz,Miriam P. Gittler,Joel P. Charles,Niklas Gremke,Ines Eckhardt,Marco Mernberger,Robert Mandic,Jurgen Thomale,Andrea Nist,Michael ...

3 Meinungen & Artikel

CRISPR-Cas9 based target validation revealed that the sensitivity of the p53-reactivating compound RITA is independent of functional p53 and is reliant on the...

Cancer cells have a characteristic metabolism, mostly caused by alterations in signal transduction networks rather than mutations in metabolic enzymes. For...

8 Webfunde aus dem Netz

Niklas Gremke Assistenzarzt : Frauenheilkunde und Geburtshilfe. Kompetenzen; Team; Info für Patienten; Info für Zuweiser

Inactivation of the p53 tumor suppressor by Mdm2 is one of the most frequent events in cancer, so compounds targeting the p53-Mdm2 interaction are promising...

for: CRISPR/Cas9-based target validation for p53-reactivating model compounds Michael Wanzel 1,5, Jonas B. Vischedyk 1, Miriam P. Gittler 1, Niklas Gremke

2020 Sep 17;11(1): doi: s Authors. Niklas Gremke , Pierfrancesco Polo , Aaron Dort , Jean Schneikert , Sabrina Elmshäuser ...

Niklas Gremke, Pierfrancesco Polo, Aaron Dort, Jean Schneikert, Sabrina Elmshäuser, Corinna Brehm, Ursula Klingmüller, Anna Schmitt, Hans Christian ...

Niklas Gremke [2]; Roland Moll [2]; Andreas Hock [1]; Andreas Rosenwald [1]; Annika C. Russ [1]; Ariane Rath [1]; Attila Braun [1]; Axel Pagenstecher [1]